Wamc- chemistry reagents

Ended Awarded Last action

Contract number
W91YTZ18F0190
Awardee
Awarding agency
Obligated
$7,105,119

Award facts

Opportunity
  • W91YTZ18R0118 Solicitation number
Contract value 100% obligated
$7,105,119.17 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Fort Liberty, NC 28310, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00017 · Wamc- chemistry reagents - DE-obligate FY23 funds -$289,474
Funding Only Action P00016 -$1,479,021
Funding Only Action P00015 · MOD fund FY23 $1,699,097
Terminate for Convenience P00014 · MOD deob FY22 chemistry testing -$237,474
Exercise an Option P00013 · MOD - exercise OY 4 FY23 SAF roche $0
Funding Only Action P00012 · MOD FY22 funding OY3 chemistry reagents SUP $1,905,097
Exercise an Option P00011 · MOD -FY22 option 3 -chemistry testing reagents $0
Supplemental Agreement for work within scope P00010 · Covid MOD add sars-COV2 for FY22 3RD option $0
Other Administrative Action P00009 $0
Funding Only Action P00008 $1,905,097
Change Order P00007 $0
Exercise an Option P00006 $0
Other Administrative Action P00005 -$203,605
Funding Only Action P00004 $1,902,702
Exercise an Option P00003 $0
Other Administrative Action P00002 $0
Funding Only Action P00001 $1,902,702
Original award $0
Show all 18

About this award

This federal contract award was made by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $7,105,119.17 Delivery Order contract is for WAMC Chemistry Reagents and is not set aside. The contract is associated with Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). This award provides clinical chemistry analyzers, reagents, and testing services to support immunochemistry, hematology, molecular diagnostics, microbiology, histology, and other laboratory capabilities at military treatment facilities across a 5-year ordering period. Roche has a history of supplying medical equipment and consumables to federal agencies including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services through prime contracts and subcontract arrangements.

Quick answers

Who was awarded contract W91YTZ18F0190?

W91YTZ18F0190 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on October 1, 2018.

How much is contract W91YTZ18F0190 worth?

The government has obligated $7,105,119 on W91YTZ18F0190.

Which agency awarded contract W91YTZ18F0190?

Medical Command (Department of the Army) awarded W91YTZ18F0190, with funding from Defense Health Agency (Department of Defense).

Is contract W91YTZ18F0190 an order under another contract?

Yes. W91YTZ18F0190 is a delivery order under V797P7347A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract W91YTZ18F0190 competed?

The extent of competition for W91YTZ18F0190 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award